A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

NCT00034593 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Urologic Neoplasms

Interventions

DRUG: ALIMTA
DRUG: gemcitabine

Sponsor

Eli Lilly and Company